Maintenance of LDL, HbA1c Goals With Pharmacist-Led Program

This article originally appeared here.
Share this content:
Maintenance of LDL, HbA1c Goals With Pharmacist-Led Program
Maintenance of LDL, HbA1c Goals With Pharmacist-Led Program

THURSDAY, Nov. 19, 2015 (HealthDay News) -- Veterans with type 2 diabetes had durable maintenance of their low-density lipoprotein (LDL) cholesterol and hemoglobin A1c (A1C) goals, but not systolic blood pressure (SBP) goals, after discharge from a pharmacist-managed ambulatory care clinic, in a study published in the November issue of Diabetes Spectrum.

P. Benjamin Erwin, Pharm.D., from the St. Louis College of Pharmacy and VA St. Louis Health Care System, and colleagues examined the ability of patients with type 2 diabetes to maintain SBP, LDL cholesterol, and A1C at goal levels after discharge from a pharmacist-managed ambulatory care clinic. Data were reviewed from the medical records of veterans with diabetes who were discharged after attaining their goal SBP, LDL cholesterol, or A1C.

The researchers found that 69 patients who were discharged from the clinic subsequently failed to maintain their goals. The mean time to failure was 9.4, 25.8, and 20.4 months, respectively, for SBP, LDL cholesterol, and A1C. For SBP and A1C goals, multiple risk factors correlated with the shorter time to failure.

"Veterans with type 2 diabetes in this study demonstrated durable maintenance of their goal LDL cholesterol and A1C levels after being discharged from a pharmacist-managed ambulatory care clinic," the authors write. "Patients who meet their SBP goal may benefit from receiving continued disease state management services from a pharmacist-managed ambulatory care clinic instead of being discharged to receive their usual care."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin

More Evidence HPV Vaccine Protects Against Cervical Cancer

More Evidence HPV Vaccine Protects Against Cervical Cancer

Protection appears to occur even when only one or two of the recommended doses are given

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Study of millions of health records suggests an association

is free, fast, and customized just for you!

Already a member?

Sign In Now »